Children and young adults (Incident) | n = 159 | n = 821 | |
Female sex | 97 (61.0) | 381 (46.4) | 0.001 |
Age at start of renal replacement therapy, yr | | | |
0 to < 5 | 16 (10.1) | 88 (10.7) | 0.94 |
5 to < 10 | 16 (10.1) | 91 (11.1) | |
10 to < 15 | 37 (23.3) | 179 (21.8) | |
15 to < 18 | 35 (22.0) | 163 (19.9) | |
18 to < 22 | 55 (34.6) | 300 (36.5) | |
Adults (75% sample) | n = 1 113 | n = 19 363 | |
Female sex | 591 (53.1) | 7 570 (39.1) | < 0.001 |
Age at start of renal replacement therapy, yr | | | |
22 to < 40 | 168 (15.1) | 2 381 (12.3) | < 0.001 |
40 to < 60 | 545 (49.0) | 5 434 (28.1) | |
≥ 60 | 400 (35.9) | 11 548 (59.6) | |
Comorbidity | | | |
Type 1 diabetes† | 296 (26.6) | 3 140 (16.2) | < 0.001 |
Type 2 diabetes† | 462 (41.5) | 3 510 (18.1) | < 0.001 |
Myocardial Infarction | 162 (14.6) | 3 889 (20.0) | < 0.001 |
Pulmonary edema | 355 (31.9) | 5 528 (28.5) | 0.02 |
Stroke or TIA | 105 (9.4) | 2 042 (10.5) | 0.24 |
Chronic lung disease | 85 (7.6) | 2 131 (11.0) | < 0.001 |
Peripheral vascular disease | 224 (20.1) | 3 595 (18.6) | 0.19 |
Malignancy | 45 (4.0) | 1 854 (9.6) | < 0.001 |